Last Funding Type: Series B
Total Funding: 249739241.0
Last Funding Date: 2020-04-01
Funding Status: IPO
Employee Number: 11-50
Estimated Revenue: $1M to $10M
Technology: Biotechnology, Health Care, Medical
Investors Number: 17.0
Founded Date: 2011-01-01
Headquarters: Cambridge, Massachusetts, United States
Industry: End-to-End Drug Development